zeposia
bristol-myers squibb pharma eeig - ozanimod hidrohlorīds - multiple sclerosis, relapsing-remitting; colitis, ulcerative - imūnsupresanti - multiple sclerosiszeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (rrms) with active disease as defined by clinical or imaging features. ulcerative colitiszeposia is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent.
mirador® forte
adama - suspensijas koncentrāts - azoksistrobīns + tebukonazols - fungicīdi
seedron®
adama - šķīstošs koncentrāts - fludioksonils + tebukonazols - citi produkti
banjo forte®
adama - suspensijas koncentrāts - dimetomorfs + fluazinams - fungicīdi